Radiometer is part of Danaher Corporation (NYSE: DHR) life sciences and diagnostics platform, offering a broad range of analyzers, consumables, software, and services used to diagnose diseases and make treatment decisions in pathology labs, hospitals, and other critical care settings.
Other life sciences and diagnostics companies owned by Danaher Corporation are HemoCue (part of the Radiometer Group), Beckman Coulter, Leica Microsystems, Leica Biosystems, Molecular Devices and AB Sciex. Founded in 1935 and headquartered in Copenhagen, Denmark, Radiometer was a pioneer in blood gas testing, introducing the world’s first commercially available blood gas analyzer in 1954.
Today, Radiometer’s products and solutions are used in hospitals, clinics and laboratories in over 130 countries, to provide information on the most critical parameters in acute care testing. In fact, six samples are performed every second on a Radiometer analyzer somewhere in the world. That’s 360 samples a minute, 21,600 samples an hour, 518,400 samples a day. That’s 189,216,000 samples every year tested on a Radiometer analyzer somewhere in the world.
Radiometer develops, manufactures and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing, and related IT management systems under the ABL, AQT, TCM, RADIANCE, AQURE, PICO, CLINITUBES, and QUALICHECK brand names.